STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Cheminformatics Review Article

Role of Carboxylesterases in Xenobiotic Metabolism and Detoxification: Insights for Cheminformatics Approaches

  1. Sakshi Chaudhary Department of Biotechnology, Dr. K.N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Ghaziabad
  2. Neetu Saharan Department of Biotechnology, Dr. K.N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Ghaziabad

Abstract

Xenobiotics, which include a wide range of environmental pollutants, food additives, drugs, and carcinogens, are foreign chemical entities that enter the human body and may accumulate, leading to toxic effects. Phase I and phase II metabolic responses are among the detoxification procedures that are necessary to lessen these negative consequences. This review highlights the pivotal role of carboxylesterases (CES), enzymes involved in the hydrolysis of ester, amide, and thioester bonds in xenobiotics, in the metabolism and detoxification of these substances. We discuss the structural and functional properties of CES, their tissue distribution, and the implications of their activity in drug metabolism and environmental toxin clearance. In the context of cheminformatics, we explore how computational models can assist in predicting CES activity, understanding substrate specificity, and designing drug molecules or inhibitors that modulate CES activity. The information presented here provides valuable insights for both pharmacological applications and environmental health assessments.

Keywords

References (59)

  1. Joseph P. Transcriptomics in toxicology. Food and Chemical Toxicology. 2017;109:650-662. doi:10.1016/j.fct.2017.07.031
  2. Mansuy D. Le métabolisme des xénobiotiques : effets bénéfiques, effets néfastes. Biologie Aujourd'hui. 2013;207(1):33-37. doi:10.1051/jbio/2013003
  3. Patterson AD, Gonzalez FJ, Idle JR. Xenobiotic Metabolism: A View through the Metabolometer. Chemical Research in Toxicology. 2010;23(5):851-860. doi:10.1021/tx100020p
  4. Detoxification and Substance Abuse Treatment Treatment Improvement Protocol (TIP) Series. (2006). Rockville (MD).
  5. Kreitinger JM, Beamer CA, Shepherd DM. Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants. The Journal of Immunology. 2016;196(8):3217-3225. doi:10.4049/jimmunol.1502149
  6. Croom E. Metabolism of Xenobiotics of Human Environments. Progress in Molecular Biology and Translational Science. 2012:31-88. doi:10.1016/b978-0-12-415813-9.00003-9
  7. Godin SJ, Scollon EJ, Hughes MF, Potter PM, DeVito MJ, Ross MK. Species Differences in the in Vitro Metabolism of Deltamethrin and Esfenvalerate: Differential Oxidative and Hydrolytic Metabolism by Humans and Rats. Drug Metabolism and Disposition. 2006;34(10):1764-1771. doi:10.1124/dmd.106.010058
  8. The Role of Carboxylesterases in Therapeutic Intervention of Nerve Gases Poisoning Sigrun Hanne Sterri, Frode Fonnum, in Handbook of Toxicology of Chemical Warfare Agents. (2015).
  9. Yan, B. (2014). Carboxylesterases. In Encyclopedia of Toxicology (pp. 695–698). Elsevier.
  10. Bachmann, K. (2009). Drug Metabolism. In Pharmacology (pp. 131–173). Elsevier.
  11. Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science. 2017;356(6344). doi:10.1126/science.aag2770
  12. Abdelsalam NA, Ramadan AT, ElRakaiby MT, Aziz RK. Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics. Frontiers in Pharmacology. 2020;11. doi:10.3389/fphar.2020.00390
  13. Clarke G, Sandhu KV, Griffin BT, Dinan TG, Cryan JF, Hyland NP. Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions. Pharmacological Reviews. 2019;71(2):198-224. doi:10.1124/pr.118.015768
  14. Wang D, Zou L, Jin Q, Hou J, Ge G, Yang L. Human carboxylesterases: a comprehensive review. Acta Pharmaceutica Sinica B. 2018;8(5):699-712. doi:10.1016/j.apsb.2018.05.005
  15. Hatfield MJ, Umans RA, Hyatt JL, Edwards CC, Wierdl M, Tsurkan L, et al. Carboxylesterases: General detoxifying enzymes. Chemico-Biological Interactions. 2016;259:327-331. doi:10.1016/j.cbi.2016.02.011
  16. Sanghani SP, Sanghani PC, Schiel MA, Bosron WF. Human Carboxylesterases: An Update on CES1, CES2 and CES3. Protein & Peptide Letters. 2009;16(10):1207-1214. doi:10.2174/092986609789071324
  17. Satoh T, Hosokawa M. Structure, function and regulation of carboxylesterases. Chemico-Biological Interactions. 2006;162(3):195-211. doi:10.1016/j.cbi.2006.07.001
  18. Satoh T, Hosokawa M. THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions. Annual Review of Pharmacology and Toxicology. 1998;38(1):257-288. doi:10.1146/annurev.pharmtox.38.1.257
  19. Ross MK, Crow JA. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. Journal of Biochemical and Molecular Toxicology. 2007;21(4):187-196. doi:10.1002/jbt.20178
  20. Hosokawa M. Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs. Molecules. 2008;13(2):412-431. doi:10.3390/molecules13020412
  21. Imai T. Human Carboxylesterase Isozymes: Catalytic Properties and Rational Drug Design. Drug Metabolism and Pharmacokinetics. 2006;21(3):173-185. doi:10.2133/dmpk.21.173
  22. Redinbo MR, Potter PM. Keynote review: Mammalian carboxylesterases: From drug targets to protein therapeutics. Drug Discovery Today. 2005;10(5):313-325. doi:10.1016/s1359-6446(05)03383-0
  23. Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, Du BNL. Current Progress on Esterases: From Molecular Structure to Function. Drug Metabolism and Disposition. 2002;30(5):488-493. doi:10.1124/dmd.30.5.488
  24. Potter P.M., Wolverton J.S., Morton C.L., Wierdl M., Danks M.K. Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. Cancer Res. 1998;58:3627–3632.
  25. Zhu HJ, Wang X, Gawronski BE, Brinda BJ, Angiolillo DJ, Markowitz JS. Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation. The Journal of Pharmacology and Experimental Therapeutics. 2013;344(3):665-672. doi:10.1124/jpet.112.201640
  26. Zhu HJ, Markowitz JS. Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants. Drug Metabolism and Disposition. 2009;37(2):264-267. doi:10.1124/dmd.108.024943
  27. Nishi K, Huang H, Kamita SG, Kim IH, Morisseau C, Hammock BD. Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2. Archives of Biochemistry and Biophysics. 2006;445(1):115-123. doi:10.1016/j.abb.2005.11.005
  28. Imai T, Ohura K. The Role of Intestinal Carboxylesterase in the Oral Absorption of Prodrugs. Current Drug Metabolism. 2010;11(9):793-805. doi:10.2174/138920010794328904
  29. Lian J, Nelson R, Lehner R. Carboxylesterases in lipid metabolism: from mouse to human. Protein & Cell. 2017;9(2):178-195. doi:10.1007/s13238-017-0437-z
  30. Alam M, Ho S, Vance DE, Lehner R. Heterologous Expression, Purification, and Characterization of Human Triacylglycerol Hydrolase. Protein Expression and Purification. 2002;24(1):33-42. doi:10.1006/prep.2001.1553
  31. Ruby MA, Massart J, Hunerdosse DM, Schönke M, Correia JC, Louie SM, et al. Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance. Cell Reports. 2017;18(3):636-646. doi:10.1016/j.celrep.2016.12.070
  32. Crow JA, Herring KL, Xie S, Borazjani A, Potter PM, Ross MK. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2010;1801(1):31-41. doi:10.1016/j.bbalip.2009.09.002
  33. Alam M, Vance DE, Lehner R. Structure−Function Analysis of Human Triacylglycerol Hydrolase by Site-Directed Mutagenesis: Identification of the Catalytic Triad and a Glycosylation Site. Biochemistry. 2002;41(21):6679-6687. doi:10.1021/bi0255625
  34. Wang DD, Zou LW, Jin Q, Hou J, Ge GB, Yang L. Recent progress in the discovery of natural inhibitors against human carboxylesterases. Fitoterapia. 2017;117:84-95. doi:10.1016/j.fitote.2017.01.010
  35. Dominguez E, Galmozzi A, Chang JW, Hsu KL, Pawlak J, Li W, et al. Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes. Nature Chemical Biology. 2013;10(2):113-121. doi:10.1038/nchembio.1429
  36. Crow JA, Middleton BL, Borazjani A, Hatfield MJ, Potter PM, Ross MK. Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2008;1781(10):643-654. doi:10.1016/j.bbalip.2008.07.005
  37. Yoon K.J.P., Hyatt J.L., Morton C.L., Lee R.E., Potter P.M., Danks M.K. Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational application. Mol Cancer Ther. 2004;3:903–909.
  38. Xu Y, Zhang C, He W, Liu D. Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review. European Journal of Drug Metabolism and Pharmacokinetics. 2016;41(4):321-330. doi:10.1007/s13318-016-0326-5
  39. Hicks LD, Hyatt JL, Stoddard S, Tsurkan L, Edwards CC, Wadkins RM, et al. Improved, Selective, Human Intestinal Carboxylesterase Inhibitors Designed to Modulate 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) Toxicity. Journal of Medicinal Chemistry. 2009;52(12):3742-3752. doi:10.1021/jm9001296
  40. Aranda J, Cerqueira NMFSA, Fernandes PA, Roca M, Tuñon I, Ramos MJ. The Catalytic Mechanism of Carboxylesterases: A Computational Study. Biochemistry. 2014;53(36):5820-5829. doi:10.1021/bi500934j
  41. Liebler DC, Guengerich FP. Elucidating mechanisms of drug-induced toxicity. Nature Reviews Drug Discovery. 2005;4(5):410-420. doi:10.1038/nrd1720
  42. Chambers JP, Hartgraves SL, Murphy MR, Wayner MJ, Kumar N, Valdes JJ. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity. Neuroscience & Biobehavioral Reviews. 1991;15(1):85-88. doi:10.1016/s0149-7634(05)80096-x
  43. Cashman JR, Perotti BY, Berkman CE, Lin J. Pharmacokinetics and molecular detoxication. Environmental Health Perspectives. 1996;104(suppl1):23-40. doi:10.1289/ehp.96104s123
  44. Jones RD, Taylor AM, Tong EY, Repa JJ. Carboxylesterases Are Uniquely Expressed among Tissues and Regulated by Nuclear Hormone Receptors in the Mouse. Drug Metabolism and Disposition. 2013;41(1):40-49. doi:10.1124/dmd.112.048397
  45. Ross MK, Crow JA. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. Journal of Biochemical and Molecular Toxicology. 2007;21(4):187-196. doi:10.1002/jbt.20178
  46. Tsujita T, Okuda H. The Synthesis of Fatty Acid Ethyl Ester by Carboxylester Lipase. European Journal of Biochemistry. 1994;224(1):57-62. doi:10.1111/j.1432-1033.1994.tb19994.x
  47. Shibata Y, Takahashi H, Chiba M, Ishii Y. Prediction of Hepatic Clearance and Availability by Cryopreserved Human Hepatocytes: An Application of Serum Incubation Method. Drug Metabolism and Disposition. 2002;30(8):892-896. doi:10.1124/dmd.30.8.892
  48. Hodgson E, Levi PE. Pesticides: an important but underused model for the environmental health sciences. Environmental Health Perspectives. 1996;104(suppl1):97-106. doi:10.1289/ehp.96104s197
  49. Spitzen J, Koelewijn T, Mukabana WR, Takken W. Effect of insecticide-treated bed nets on house-entry by malaria mosquitoes: The flight response recorded in a semi-field study in Kenya. Acta Tropica. 2017;172:180-185. doi:10.1016/j.actatropica.2017.05.008
  50. Clark NWE, Scott RC, Blain PG, Williams FM. Fate of fluazifop butyl in rat and human skin in vitro. Archives of Toxicology. 1993;67(1):44-48. doi:10.1007/bf02072034
  51. Cantalamessa F. Acute toxicity of two pyrethroids, permethrin, and cypermethrin in neonatal and adult rats. Archives of Toxicology. 1993;67(7):510-513. doi:10.1007/bf01969923
  52. Casida JE, Ueda K, Gaughan LC, Jao LT, Soderlund DM. Structure-biodegradability relationships in pyrethroid insecticides. Archives of Environmental Contamination and Toxicology. 1975;3(4):491-500. doi:10.1007/bf02220819
  53. Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochemical Pharmacology. 1994;48(9):1747-1755. doi:10.1016/0006-2952(94)90461-8
  54. Durrer A, Walther B, Racciatti A, Boss G, Testa B. Structure–Metabolism Relationships in the Hydrolysis of Nicotinate Esters by Rat Liver and Brain Subcellular Fractions. Pharmaceutical Research. 1991;8(7):832-839. doi:10.1023/a:1015839109449
  55. Inoue, M., Morikawa, M., Tsuboi, M., Ito, Y., & Sugiura, M. (1980). Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolizing activity for ester-type drugs. The Japanese Journal of Pharmacology, 30(4), 529–535. doi:10.1254/jjp.30.529
  56. LUTTRELL WE, CASTLE MC. Species Differnces in the Hydrolysis of Meperdine and its Inhibition by Organophosphate Compounds. Toxicological Sciences. 1988;11(1):323-332. doi:10.1093/toxsci/11.1.323
  57. STOTT W. Hydrolysis of several glycol ether acetates and acrylate esters by nasal mucosal carboxylesterase in vitro. Fundamental and Applied Toxicology. 1985;5(2):399-404. doi:10.1016/0272-0590(85)90088-0
  58. Potter P, Wadkins R. Carboxylesterases - Detoxifying Enzymes and Targets for Drug Therapy. Current Medicinal Chemistry. 2006;13(9):1045-1054. doi:10.2174/092986706776360969
  59. Wikipedia contributors. (2024, July 7). Drug metabolism. Retrieved from Wikipedia, The Free Encyclopedia website: https://en.wikipedia.org/w/index.php?title=Drug_metabolism&oldid=1233160811